This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
September 17, 2025
Videos
Peer-to-Peer Clinical Conversations
Comparing Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia - Dean Elterman
Dean Elterman
Alan Wein is joined by Dean Elterman to discuss BPH procedure selection based on patient characteristics and preferences.
View
A Discussion on the Field of Men's Health and Gender-Specific Medicine - Bruce Kava
Bruce Kava
Alan Wein speaks with Bruce Kava about the field of men's health.
View
Articles
Editor Selected Abstracts and Commentaries
Male Infertility
Expression of miR-339-3p and OPRM1 in relation to sperm function in male infertility.
Congenital Fusion of Spermatic Cords With Unilateral Seminal Vesicle Agenesis and Ipsilateral Varicocele in an Adult Male With Oligospermia: A Report of a Rare Case.
Diabetic testicular dysfunction and spermatogenesis impairment: mechanisms and therapeutic prospects.
Peyronie's Disease
Late-Onset Penile Fracture After Collagenase Clostridium histolyticum Treatment for Peyronie's Disease in a 70-Year-Old Patient.
Erectile Dysfunction
Factors associated with erectile dysfunction in men with lower urinary tract symptoms (LUTS): a Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) study.
Early Continence and Erectile Function Recovery Following Transvesical Single-Port Robot-Assisted Radical Prostatectomy: Initial Single Institution Experience.
Managing Erectile Dysfunction After Pelvic Radiotherapy.
Erectile Function in Patients With Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Delayed Anastomotic Urethroplasty?
Erectile Function in Patients With Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Delayed Anastomotic Urethroplasty?
Erectile Function in Patients With Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Delayed Anastomotic Urethroplasty?
Erectile Function in Patients With Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Delayed Anastomotic Urethroplasty?
Erectile Function in Patients With Pelvic Fracture Urethral Injury: What Are the Predictors of Persistent Severe Erectile Dysfunction After Delayed Anastomotic Urethroplasty?
BPH - Benign Prostatic Enlargement
Diode laser enucleation prostate for benign prostatic hyperplasia: outcomes of the Leonardi ejaculation sparing technique.
Real-World Clinical Outcomes of Transperineal Laser Ablation in BPH: A 12-Month Retrospective Analysis.
Comparison of Perioperative Outcomes for Prostate Artery Embolization Versus Transurethral Resection of the Prostate and Laser Enucleation for Benign Prostatic Hyperplasia: Results from the GRAND Study.
Shifts in clinical practice and patient demographics following the introduction of holmium laser enucleation for benign prostatic hyperplasia in a general urology clinic.
Penile & Urethral Cancers
Single-cell transcriptomic profiling reveals distinct tumor microenvironments in HPV-associated penile squamous cell carcinoma.
Characterization of CD8+ and FOXP3+ T-Cell Ratios in Tumor and Stromal Compartments of Penile Squamous Cell Carcinoma: An Analysis Across Histologic Subtypes and Grades.
Survivin and Ki-67 Immunohistochemical Expression in Penile Squamous Cell Carcinoma: Clinicopathological Features and Overall Survival - Beyond the Abstract
Testicular Cancer
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study.
Retroperitoneal lymphadenectomy (RPLND) for the treatment of testicular germ cell tumors-open or robotic? Pro open surgery : RPLND in the management of testis cancer.
Role of radiotherapy in the management of testicular cancer: Recommendations from the French society for radiation oncology.
Physical morbidities in survivors of testicular germ cell tumors during childhood, adolescence, and young adulthood: a population-based retrospective matched cohort study.
Prostate Cancer
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology.
Managing Drug Interactions with Enzalutamide in Patients with Prostate Cancer: A Podcast.
Association between insulin resistance and prostate volume: A 4-year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial.
The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast.
High-Dose-Rate brachytherapy for salvage treatment of prostate cancer recurrence post-prostatectomy and radiotherapy: A multicenter retrospective analysis (HDR-REPOPRA) by UroGEC.
A double-negative prostate cancer subtype is vulnerable to SWI/SNF-targeting degrader molecules.
Impact of Diabetes and Metformin on Cardiovascular Outcomes in Prostate Cancer Patients Aged 66 and Older: The Role of Social Determinants of Health and Racial Disparities †.
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis.
Comparing the safety and efficacy of systemic therapies for high-risk biochemically recurrent hormone-sensitive prostate cancer: a network meta-analysis.
Tailoring Treatment in Localized Prostate Cancer: Comparative Effectiveness of HIFU, Cryoablation, and Robot-Assisted Radical Prostatectomy at 2-Year Follow-Up: Insights from Prospective Institutional Cohort.
MRI-fusion biopsy era: the role of perineural invasion in low-risk prostate cancer.
SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis.
A Narrative Review of Treatment Options for Patients with Node-Positive Disease After Radical Prostatectomy: Current Evidence and Controversies.
Comparative Economic Evaluation of Radical Prostatectomy, Radiation, and Ablative Techniques in the Management of Localized Prostate Cancer.
Prognostic Significance of PTEN Loss in Prostate Cancer: A Meta-Analysis of Gleason Grade and Clinical Outcomes.
Artificial Intelligence-Assisted Biparametric MRI for Detecting Prostate Cancer-A Comparative Multireader Multicase Accuracy Study.
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087).
Anxiety and Health-related Quality of Life in Men with Prostate Cancer Undergoing Focal Therapy: A Prospective Single-arm Phase 2 Trial.
Ultrahypofractionated radiotherapy in one or two sessions for localized prostate cancer: a review of the evidence and future perspectives.
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial.
Algorithm to detect ISUP ≥ 2 prostate cancer using canine detection.
Medicolegal landscape of prostate cancer ablative therapy: a national legal database analysis of malpractice claims (1970-2024).
Impact of Testosterone Recovery on Oncologic Outcomes in High-Risk, Localized Prostate Cancer.
Drug targets in prostate cancer: an appetite for KLK2-mediated destruction.
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomy.
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate Cancer.
ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001
Outcomes of Novel Hormonal Therapies in Men With Advanced Prostate Cancer by Treating Specialist.
Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals.
Prediction of metastasis-free survival in patients with localized prostate adenocarcinoma using primary tumor and lymph node radiomics from pre-treatment PSMA-PET/CT scans.
Comparative Effectiveness of Management Strategies for Stage IV Prostate Cancer: A Narrative Review.
Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis.
Isoform-specific function of NSD3 in DNA replication stress confers resistance to PARP inhibitors in prostate cancer.
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models.
BET inhibitors reduce tumor growth in preclinical models of gastrointestinal gene signature-positive castration-resistant prostate cancer.
YY1 enhances HIF-1α stability in tumor-associated macrophages to suppress anti-tumor immunity of prostate cancer in mice.
Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer.
Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC.
NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling.
Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy.
TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications.
Association Between Race and Detection of Clinically Significant Prostate Cancer in Transperineal and Transrectal Biopsies.
Inflammatory bowel disease vs. adverse in-hospital outcomes after radical prostatectomy.
PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer.
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer.
Urinary organs-at-risk for radiotherapy following radical prostatectomy: contouring guidelines on behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
Reproducibility of Statistically Significant Phase III Oncology Trials: An in Silico Meta-Epidemiological Analysis - Beyond the Abstract
Prostate Specific Membrane Antigen Focal Ablation Imaging (PSMA-FAB) - Beyond the Abstract
Analysis of the Current Surgical Anatomical Knowledge of Radical Prostatectomy: An Updated Review - Beyond the Abstract
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2025 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
